Caplin Point Laboratories Q4 Results

  • BSE: 524742
  • NSE: CAPLIPOINT
  • ISIN: INE475E01026
  • Sector: Biotechnology & Drugs
BSE
1,726.00-50.75 (-2.86%)
Volume5.12 K
Updated: Wed 21 Jan, 2026 | 15:29:38
NSE
1,739.20-43.40 (-2.43%)
Volume1.16 L
Updated: Wed 21 Jan, 2026 | 15:40:52
Today: 1,707.80
1,785.80
52-Wk: 1,551.05
2,396.95

Q4 Results Highlights

Quarter ended Mar 25

    Note: Comparison is on QoQ basis

    Quarterly - Caplin Point Laboratories Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 25Dec 24QoQ CompMar 24YoY Comp
    Total Operating Expense 351.43346.871.31%324.398.34%
    Depreciation/ Amortization 17.0416.205.19%16.403.90%
    Operating Income 151.02146.093.37%128.8317.22%
    Net Income 142.57138.962.60%121.5917.25%
    Other Operating Expenses Total 10.0088.55-88.71%6.1363.13%
    Net Income Before Taxes 176.67177.26-0.33%146.0320.98%
    Total Revenue 502.45492.961.93%453.2210.86%
    Selling/ General/ Admin Expenses Total 46.5146.77-0.56%36.7726.49%
    Diluted Normalized EPS 18.7018.192.82%15.9017.65%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market